Congratulations to Zachary Brunko, PharmD candidate at the University of Minnesota College of Pharmacy, for completing AMCP Foundation’s first inaugural internship devoted to addressing health inequities.
AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered internships on oncology, health outcomes, nonprofit leadership, and evidence, through the generous support of Pfizer Inc and AbbVie Inc.
With Congress back to work after the midterm elections, AMCP remains focused on the critical window that remains to pass important pieces of health legislation this year. In this blog post, AMCP CEO Susan Cantrell provides an exciting update on our legislative priority, the Pre-Approval Information Exchange (PIE) Act.
Congratulations to Kathryn DeStefano, Matthew Dickson, and Weston Schmutz, the recipients of AMCP Foundation’s Best Poster Awards at Nexus 2022. This semiannual competition, proudly presented by AMCP Foundation with support from CVS Health, culminates twice a year at AMCP national meetings.
Given the current complexities of the Medicaid, Children's Health Insurance Program (CHIP), and Basic Health Program enrollment processes, AMCP submitted comments in response to a September 7 Notice of Proposed Rulemaking (NPRM) from the Centers for Medicare and Medicaid Services (CMS). Dated November 4, AMCP's comments support the NPRM's proposed goal to simplify the enrollment process for these vital health programs. The comments specifically address the cycle of enrollment and disenrollment that program beneficiaries face, often referred to as “eligibility churn."
The Centers for Medicare and Medicaid Services (CMS) unveiled a Request for Information (RFI) titled "Make Your Voice Heard" on September 6. The RFI sought public input on healthcare accessibility, understanding provider experiences, advancing health equity, and assessing the impact of waivers and flexibilities provided in response to the COVID-19 Public Health Emergency. On November 4, AMCP responded with a comment letter offering insights into challenges related to access to medication. The comments also offer recommendations for advancing health equity within CMS.
Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
On August 4, the Department of Health and Human Services released a Notice of Proposed Rulemaking on Nondiscrimination in Health Programs and Activities. In response, AMCP submitted comments on September 29 which applaud the Department's goal to reinstate regulatory protections from discrimination in covered health programs and activities.
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.